Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication
Product Specifications Form: Lyophilized powder Amount: 10mg total (5mg CJC-1295 No DAC + 5mg Ipamorelin) Purity: 98% Appearance: White to off-white powder Molecular Information CJC-1295 No DAC Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Gly-Ser Ipamorelin Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH CAS (CJC-1295 No DAC): 863288-34-0 CAS (Ipamorelin): 170851-70-4 Research Applications Peptide-receptor interaction research Cellular signaling pathway investigations Neuroendocrine pathway research models Multi-peptide interaction studies in controlled laboratory environments Storage Store lyophilized material in a cool, dry environment
For a broader view of peptide pharmacology and why some molecules tolerate long-acting formats better than others, see our reference on peptide pharmacology and profiles such as semaglutide (weekly), which illustrates why extended exposure often comes with GI tradeoffs
Side-by-side breakdowns to help you choose
The tripeptide glycyl-L-histidyl-L-lysine binds to copper ions, creating a complex that your body recognizes as a wound-healing signal
& Jain, M
